Ecoglip-TM Tablet PR
Ecoglip-TM Tablet PR
Metformin (500mg) + Teneligliptin (20mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Ecoglip-TM Tablet PR: Helping Manage Type 2 Diabetes
Ecoglip-TM Tablet PR is a once-daily combination tablet containing metformin (500mg) and teneligliptin (20mg), used for the treatment of type 2 diabetes. This unique formula combines the proven effectiveness of metformin, an established first-line treatment, with teneligliptin's selective action to improve glycemic control.
Metformin: By lowering blood glucose levels through several mechanisms, it plays a key role in managing long-term blood sugar control for type 2 diabetes.
Teneligliptin: This dipeptidyl peptidase-4 (DPP-4) inhibitor enhances the body's ability to produce incretin hormones, which further help regulate blood glucose levels.
Ecoglip-TM Tablet PR is recommended as a standalone treatment for type 2 diabetes or in combination with other medications prescribed by your healthcare professional.
Note: It’s crucial to consult with a doctor before starting any new medication, including Ecoglip-TM Tablet PR. They can provide personalized advice and ensure the product is suitable for your specific needs.
Active composition
Metformin 500 mg
+1 more active ingredient
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Teneligliptin
Teneligliptin inhibits DPP-4, increasing incretin levels and enhancing insulin secretion.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Ecoglip-TM Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Ecoglip-TM Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Ecoglip-TM Tablet PR should be used with caution in patients with kidney disease. Dose adjustment of Ecoglip-TM Tablet PR may be needed. Please consult your doctor. Use of Ecoglip-TM Tablet PR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Exercise Caution
Breastfeeding
It is not known whether Ecoglip-TM Tablet PR alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Consult Doctor
Kidney
Ecoglip-TM Tablet PR is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Ecoglip-TM Tablet PR
Products matching your search
Gabaride NT 400mg/10mg Tablet
Gabaride NT 400mg/10mg Tablet
Childo-M 1000 Tablet
Childo-M 1000 Tablet
Glyxer M 2 Tablet SR
Glyxer M 2 Tablet SR
Wellboon Tablet
Wellboon Tablet
Gabyne N 100mg/10mg Tablet
Gabyne N 100mg/10mg Tablet
Ethasyl 250 Tablet
Ethasyl 250 Tablet
Maintane 250 Injection
Maintane 250 Injection
Endonok Tablet